12.10.25 -- Building An Oral Vaccine Platform With Vaxart's Sean Tucker, Ph.D.

Explore regulatory framework and expectations, and see the benefit of a comprehensive approach to CCI tailored for mAbs and complex modalities such as fusion proteins or bioconjugates.

Learn how a multinational pharmaceutical company successfully implemented a global strategy for insulin cartridge filling, achieving seamless regulatory approval with zero deviations.

Endotoxins can cause major upheaval in downstream purification. Explore case studies using various resins that have been successfully used for endotoxin removal.

It’s time to look at how new protein A technologies may replace resin-based methods and enable more productive and flexible purification.

Explore a case study using a specific HCP immunoassay and advanced orthogonal Antibody Affinity Extraction and Mass Spectrometry methods for assay qualification.

A novel protein A-based agarose resin has been developed to address the challenges of host cell proteins (HCP) in monoclonal antibody production.

Need to change your viral inactivation method due to environmental concerns? Don’t underestimate how long it will take to change your process.

Discover common pitfalls in cell washing and pre-formulation, including incomplete contaminant removal, manual handling, and throughput issues that compromise product quality and efficiency.

Overcome the challenges of membrane protein purification for cryo-EM. Learn essential quality control techniques to ensure your samples are homogenous and suitable for downstream structural analysis.

The monoclonal antibody intermediate is engineered for precise delivery of the linker-payload complex. Discover how rigorous storage measures that are crucial for successful conjugation and functionality.